Sponsor pipeline

Vanda Pharmaceuticals clinical trial pipeline

Get alerts when Vanda Pharmaceuticals's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.

Notable

Open-Labeled Iloperidone in Adolescents

Primary completion pushed from Mar 31, 2026 to Dec 31, 2028

Also in this update: Study completion pushed from Nov 30, 2026 to Dec 31, 2028

Vanda PharmaceuticalsPhase 4 NCT05648591 Registry history of NCT05648591 on ClinicalTrials.gov (opens the registry)

Oct 1, 2026

Show 4 trials with minor changes only

Minor

Tradipitant in Idiopathic and Diabetic Gastroparesis

Trial completed

Also in this update: Final enrollment: 17 participants (planned 100); Primary completion date changed from estimate of Dec 2025 to Mar 30, 2026

Vanda PharmaceuticalsPhase 3 NCT06836557 Registry history of NCT06836557 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

Trial completed

Also in this update: Final enrollment: 43 participants (planned 70)

Vanda PharmaceuticalsPhase 3 NCT04652882 Registry history of NCT04652882 on ClinicalTrials.gov (opens the registry)

Oct 9, 2026
Minor

Milsaperidone as Adjunctive Therapy · Major Depressive Disorder

Trial sites expanded: 38 → 53 locations

Vanda PharmaceuticalsPhase 3 NCT06830044 Registry history of NCT06830044 on ClinicalTrials.gov (opens the registry)

Sep 24, 2026
Minor

Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Trial sites expanded: 4 → 10 locations

Vanda PharmaceuticalsPhase 3 NCT07362017 Registry history of NCT07362017 on ClinicalTrials.gov (opens the registry)

Sep 22, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1		1
Phase 1/2		1
Phase 2		3
Phase 3		10
Phase 4		1

Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Schizophrenia (2) · Anxiety (1) · Bipolar Disorder (1) · Depression (1) · Hypertension (1) · Obesity (1) · Psoriasis (1) · Ulcerative Colitis (1)

Get alerts when Vanda Pharmaceuticals's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free